ID   CABC1_PROVU             Reviewed;        1021 AA.
AC   P59807; D0V0C9;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 2.
DT   03-AUG-2022, entry version 91.
DE   RecName: Full=Chondroitin sulfate ABC endolyase;
DE            EC=4.2.2.20;
DE   AltName: Full=Chondroitin ABC endoeliminase;
DE   AltName: Full=Chondroitin ABC lyase I;
DE   AltName: Full=Chondroitin sulfate ABC lyase I;
DE            Short=ChS ABC lyase I;
DE   AltName: Full=Chondroitinase ABC I;
DE            Short=cABC I;
DE   AltName: Full=Endochondroitinase ABC;
DE   AltName: INN=Condoliase;
DE   Flags: Precursor;
OS   Proteus vulgaris.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Morganellaceae; Proteus.
OX   NCBI_TaxID=585;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 25-42, CATALYTIC
RP   ACTIVITY, AND INDUCTION.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RX   PubMed=7512814; DOI=10.1007/bf00166079;
RA   Sato N., Shimada M., Nakajima H., Oda H., Kimura S.;
RT   "Cloning and expression in Escherichia coli of the gene encoding the
RT   Proteus vulgaris chondroitin ABC lyase.";
RL   Appl. Microbiol. Biotechnol. 41:39-46(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ryan M.J., Khandke K.M., Tilley B.C., Lotvin J.A.;
RT   "Cloning and expression of the chondroitinase I and II genes from Proteus
RT   vulgaris.";
RL   Patent number WO9425567, 10-NOV-1994.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-1021.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RA   Tam K.W., Wang Q., Li R.A., Chan Y.S., Shum D.K.Y.;
RT   "Use of chondroitin sulfate lyases in combination for promotion of neurite
RT   growth.";
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, ACTIVITY REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RX   PubMed=9083041; DOI=10.1074/jbc.272.14.9123;
RA   Hamai A., Hashimoto N., Mochizuki H., Kato F., Makiguchi Y., Horie K.,
RA   Suzuki S.;
RT   "Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding
RT   tetrasaccharides and an exoeliminase preferentially acting on
RT   oligosaccharides.";
RL   J. Biol. Chem. 272:9123-9130(1997).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ACTIVE SITE RESIDUES, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ARG-500; HIS-501; TYR-508; ARG-560; HIS-561; GLU-653 AND HIS-712.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RX   PubMed=15691229; DOI=10.1042/bj20041222;
RA   Prabhakar V., Capila I., Bosques C.J., Pojasek K., Sasisekharan R.;
RT   "Chondroitinase ABC I from Proteus vulgaris: cloning, recombinant
RT   expression and active site identification.";
RL   Biochem. J. 386:103-112(2005).
RN   [6]
RP   CATALYTIC ACTIVITY, ACTIVE SITE RESIDUES, AND MUTAGENESIS OF ARG-500;
RP   HIS-501; TYR-508; ARG-560 AND GLU-653.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RX   PubMed=16108757; DOI=10.1042/bj20050532;
RA   Prabhakar V., Raman R., Capila I., Bosques C.J., Pojasek K.,
RA   Sasisekharan R.;
RT   "Biochemical characterization of the chondroitinase ABC I active site.";
RL   Biochem. J. 390:395-405(2005).
RN   [7]
RP   ROLE IN DAMAGED CNS RECOVERY.
RX   PubMed=17572406; DOI=10.1016/j.expneurol.2007.05.001;
RA   Crespo D., Asher R.A., Lin R., Rhodes K.E., Fawcett J.W.;
RT   "How does chondroitinase promote functional recovery in the damaged CNS?";
RL   Exp. Neurol. 206:159-171(2007).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SODIUM ION, DOMAIN,
RP   AND DISCUSSION OF SEQUENCE.
RC   STRAIN=ATCC 6896 / NBRC 3988 / NCIMB 8065 / NCTC 4636;
RX   PubMed=12706721; DOI=10.1016/s0022-2836(03)00345-0;
RA   Huang W., Lunin V.V., Li Y., Suzuki S., Sugiura N., Miyazono H., Cygler M.;
RT   "Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at
RT   1.9A resolution.";
RL   J. Mol. Biol. 328:623-634(2003).
CC   -!- FUNCTION: Endolytic, broad-specificity glycosaminoglycan lyase, which
CC       degrades the polysaccharides chondroitin, chondroitin-4-sulfate,
CC       chondroitin-6-sulfate, dermatan sulfate and to a lesser extent
CC       hyaluronan, by beta-elimination of 1,4-hexosaminidic bond to
CC       unsaturated tetrasaccharides and disaccharides. Is not active against
CC       keratan sulfate, heparan sulfate, and heparin. Is able to promote
CC       functional recovery in the injured central nervous system (CNS), via
CC       its role in the disruption of the normal organization of the
CC       extracellular matrix (ECM). {ECO:0000269|PubMed:15691229,
CC       ECO:0000269|PubMed:17572406, ECO:0000269|PubMed:9083041}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endolytic cleavage of (1->4)-beta-galactosaminic bonds between
CC         N-acetylgalactosamine and either D-glucuronic acid or L-iduronic acid
CC         to produce a mixture of Delta(4)-unsaturated oligosaccharides of
CC         different sizes that are ultimately degraded to Delta(4)-unsaturated
CC         tetra- and disaccharides.; EC=4.2.2.20;
CC         Evidence={ECO:0000269|PubMed:15691229, ECO:0000269|PubMed:16108757,
CC         ECO:0000269|PubMed:7512814, ECO:0000269|PubMed:9083041};
CC   -!- ACTIVITY REGULATION: Is inhibited by Zn(2+), Ni(2+), Fe(2+) and Cu(2+).
CC       {ECO:0000269|PubMed:9083041}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=66 uM for chondroitin 6-sulfate {ECO:0000269|PubMed:15691229,
CC         ECO:0000269|PubMed:9083041};
CC         KM=1.2 uM for chondroitin 6-sulfate {ECO:0000269|PubMed:15691229,
CC         ECO:0000269|PubMed:9083041};
CC         KM=1.5 uM for chondroitin 4-sulfate {ECO:0000269|PubMed:15691229,
CC         ECO:0000269|PubMed:9083041};
CC         KM=2.5 uM for dermatan sulfate {ECO:0000269|PubMed:15691229,
CC         ECO:0000269|PubMed:9083041};
CC         Vmax=310 umol/min/mg enzyme with chondroitin 6-sulfate as substrate
CC         {ECO:0000269|PubMed:15691229, ECO:0000269|PubMed:9083041};
CC       pH dependence:
CC         Optimum pH is 8. Is essentially inactive at pH 9.0.
CC         {ECO:0000269|PubMed:15691229, ECO:0000269|PubMed:9083041};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:15691229, ECO:0000269|PubMed:9083041};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:12706721}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000305|PubMed:15691229}.
CC   -!- INDUCTION: By chondroitin sulfate or its degraded products.
CC       {ECO:0000269|PubMed:7512814}.
CC   -!- DOMAIN: Consists of three domains. The middle domain contains the
CC       catalytic site in a wide-open cleft. {ECO:0000269|PubMed:12706721}.
CC   -!- SIMILARITY: Belongs to the polysaccharide lyase 8 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: PubMed:7512814 shows amino acid differences at positions 317,
CC       321, 410, 694, 738 and 866 due to incorrect translation of the
CC       nucleotide sequence. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=Ref.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ996964; ACY01450.1; -; Genomic_DNA.
DR   PDB; 1HN0; X-ray; 1.90 A; A=1-1021.
DR   PDB; 7EIP; X-ray; 1.88 A; A=1-1021.
DR   PDB; 7EIQ; X-ray; 1.80 A; A=1-1021.
DR   PDB; 7EIR; X-ray; 1.92 A; A=1-1021.
DR   PDB; 7EIS; X-ray; 2.50 A; A=1-1021.
DR   PDBsum; 1HN0; -.
DR   PDBsum; 7EIP; -.
DR   PDBsum; 7EIQ; -.
DR   PDBsum; 7EIR; -.
DR   PDBsum; 7EIS; -.
DR   AlphaFoldDB; P59807; -.
DR   SMR; P59807; -.
DR   IntAct; P59807; 2.
DR   MINT; P59807; -.
DR   STRING; 585.DR95_2846; -.
DR   CAZy; PL8; Polysaccharide Lyase Family 8.
DR   eggNOG; ENOG502Z8J1; Bacteria.
DR   BioCyc; MetaCyc:MON-15788; -.
DR   BRENDA; 4.2.2.20; 5049.
DR   EvolutionaryTrace; P59807; -.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0034000; F:chondroitin-sulfate-ABC endolyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; IEA:InterPro.
DR   Gene3D; 1.50.10.100; -; 1.
DR   Gene3D; 2.60.220.10; -; 1.
DR   Gene3D; 2.70.98.10; -; 1.
DR   InterPro; IPR039174; Chondroitin_ABC_lyase.
DR   InterPro; IPR008929; Chondroitin_lyas.
DR   InterPro; IPR024200; Chondroitinase_ABC_I.
DR   InterPro; IPR011013; Gal_mutarotase_sf_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR014718; GH-type_carb-bd.
DR   InterPro; IPR011071; Lyase_8-like_C.
DR   InterPro; IPR003159; Lyase_8_central_dom.
DR   InterPro; IPR015177; Lyase_catalyt.
DR   InterPro; IPR015176; Lyase_N.
DR   PANTHER; PTHR37322; PTHR37322; 1.
DR   Pfam; PF02278; Lyase_8; 1.
DR   Pfam; PF09093; Lyase_catalyt; 1.
DR   Pfam; PF09092; Lyase_N; 1.
DR   PIRSF; PIRSF034515; Chondroitinase; 1.
DR   SUPFAM; SSF48230; SSF48230; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49863; SSF49863; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Carbohydrate metabolism; Direct protein sequencing;
KW   Lyase; Metal-binding; Periplasm; Signal; Sodium.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000269|PubMed:7512814"
FT   CHAIN           25..1021
FT                   /note="Chondroitin sulfate ABC endolyase"
FT                   /id="PRO_0000024929"
FT   ACT_SITE        501
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   ACT_SITE        508
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255"
FT   BINDING         43
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000269|PubMed:12706721,
FT                   ECO:0007744|PDB:1HN0"
FT   BINDING         70
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000269|PubMed:12706721,
FT                   ECO:0007744|PDB:1HN0"
FT   BINDING         73
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000269|PubMed:12706721,
FT                   ECO:0007744|PDB:1HN0"
FT   BINDING         211
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /evidence="ECO:0000269|PubMed:12706721,
FT                   ECO:0007744|PDB:1HN0"
FT   SITE            560
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255"
FT   SITE            653
FT                   /note="Important for catalytic activity"
FT   MUTAGEN         500
FT                   /note="R->A: Still active on both chondroitin 6-sulfate and
FT                   dermatan sulfate, but with highly reduced catalytic
FT                   efficiency."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         501
FT                   /note="H->A,K,R: Loss of activity on both chondroitin
FT                   6-sulfate and dermatan sulfate."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         508
FT                   /note="Y->A: Loss of activity on both chondroitin 6-sulfate
FT                   and dermatan sulfate."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         508
FT                   /note="Y->F: Still active on both chondroitin 6-sulfate and
FT                   dermatan sulfate, but with greatly reduced catalytic
FT                   efficiency."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         560
FT                   /note="R->A: Loss of activity on both chondroitin 6-sulfate
FT                   and dermatan sulfate."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         561
FT                   /note="H->A: Still active on both chondroitin 6-sulfate and
FT                   dermatan sulfate, but with reduced catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:15691229"
FT   MUTAGEN         653
FT                   /note="E->A,D: Loss of activity on both chondroitin
FT                   6-sulfate and dermatan sulfate."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         653
FT                   /note="E->Q: Still active on both chondroitin 6-sulfate and
FT                   dermatan sulfate, but with reduced catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:15691229,
FT                   ECO:0000269|PubMed:16108757"
FT   MUTAGEN         712
FT                   /note="H->A: Still active on both chondroitin 6-sulfate and
FT                   dermatan sulfate, but with reduced catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:15691229"
FT   CONFLICT        125
FT                   /note="L -> P (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="M -> V (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        670
FT                   /note="A -> G (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        865
FT                   /note="S -> R (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           33..35
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          59..66
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          74..80
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          84..88
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           96..103
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          104..119
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          122..132
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          141..146
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          151..158
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          194..198
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          203..219
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           251..269
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           283..291
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          303..305
FT                   /evidence="ECO:0007829|PDB:7EIR"
FT   HELIX           313..317
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           324..330
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           336..352
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           356..375
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           390..403
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           405..410
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           414..424
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           425..428
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           429..432
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            438..441
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           443..448
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           450..458
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           463..482
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          490..492
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           506..523
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           532..547
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          549..553
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           555..557
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           568..571
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           572..580
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           588..598
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           602..609
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          621..625
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           626..628
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          630..635
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          638..643
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          649..651
FT                   /evidence="ECO:0007829|PDB:1HN0"
FT   HELIX           662..664
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          667..676
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           679..681
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          697..699
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           703..706
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          709..712
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          719..721
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          724..728
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            729..731
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          732..740
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          753..761
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          764..773
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            775..780
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          781..789
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          792..794
FT                   /evidence="ECO:0007829|PDB:7EIP"
FT   STRAND          797..799
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          802..804
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          807..813
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          818..820
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          826..831
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          835..845
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            847..849
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          852..863
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           864..866
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          867..878
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   HELIX           883..894
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          898..914
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   TURN            915..918
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          919..926
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          933..949
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          952..958
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          966..968
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          973..981
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          983..986
FT                   /evidence="ECO:0007829|PDB:1HN0"
FT   STRAND          993..997
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          1000..1008
FT                   /evidence="ECO:0007829|PDB:7EIQ"
FT   STRAND          1013..1019
FT                   /evidence="ECO:0007829|PDB:7EIQ"
SQ   SEQUENCE   1021 AA;  115092 MW;  299406E6466568AC CRC64;
     MPIFRFTALA MTLGLLSAPY NAMAATSNPA FDPKNLMQSE IYHFAQNNPL ADFSSDKNSI
     LTLSDKRSIM GNQSLLWKWK GGSSFTLHKK LIVPTDKEAS KAWGRSSTPV FSFWLYNEKP
     IDGYLTIDFG EKLISTSEAQ AGFKVKLDFT GWRAVGVSLN NDLENREMTL NATNTSSDGT
     QDSIGRSLGA KVDSIRFKAP SNVSQGEIYI DRIMFSVDDA RYQWSDYQVK TRLSEPEIQF
     HNVKPQLPVT PENLAAIDLI RQRLINEFVG GEKETNLALE ENISKLKSDF DALNIHTLAN
     GGTQGRHLIT DKQIIIYQPE NLNSQDKQLF DNYVILGNYT TLMFNISRAY VLEKDPTQKA
     QLKQMYLLMT KHLLDQGFVK GSALVTTHHW GYSSRWWYIS TLLMSDALKE ANLQTQVYDS
     LLWYSREFKS SFDMKVSADS SDLDYFNTLS RQHLALLLLE PDDQKRINLV NTFSHYITGA
     LTQVPPGGKD GLRPDGTAWR HEGNYPGYSF PAFKNASQLI YLLRDTPFSV GESGWNNLKK
     AMVSAWIYSN PEVGLPLAGR HPFNSPSLKS VAQGYYWLAM SAKSSPDKTL ASIYLAISDK
     TQNESTAIFG ETITPASLPQ GFYAFNGGAF GIHRWQDKMV TLKAYNTNVW SSEIYNKDNR
     YGRYQSHGVA QIVSNGSQLS QGYQQEGWDW NRMQGATTIH LPLKDLDSPK PHTLMQRGER
     GFSGTSSLEG QYGMMAFDLI YPANLERFDP NFTAKKSVLA ADNHLIFIGS NINSSDKNKN
     VETTLFQHAI TPTLNTLWIN GQKIENMPYQ TTLQQGDWLI DSNGNGYLIT QAEKVNVSRQ
     HQVSAENKNR QPTEGNFSSA WIDHSTRPKD ASYEYMVFLD ATPEKMGEMA QKFRENNGLY
     QVLRKDKDVH IILDKLSNVT GYAFYQPASI EDKWIKKVNK PAIVMTHRQK DTLIVSAVTP
     DLNMTRQKAA TPVTINVTIN GKWQSADKNS EVKYQVSGDN TELTFTSYFG IPQEIKLSPL
     P
//
